A Decade of Innovation: CAR-T Successes and Latest Developments
July 6, 2022After a decade of innovation, chimeric antigen receptor (CAR)-T cell therapy remains at the forefront of the cell and gene therapy space, continuing to forge new ground to treat previously […]
Why You Should Start Clinical Grade Cell Supply Discussions Early in Cell and Gene Therapy Development
May 24, 2022Cell and gene therapies represent an expanding category of transformative medicines with the potential to change the way we treat human diseases. Broadly, these novel therapies include both in vivo […]
What You Need to Know About Regenerative Medicine in 2022: Industry and Tech Trends
April 20, 2022Growth in the Regenerative Medicine Field The regenerative medicine sector is on track for another watershed year where clinical progress, continued growth, and segmentation into new disease areas affecting larger […]
AllCells Opens a New Collection Facility in Houston, Texas
March 29, 2022Expanding Its Donor Network AllCells, the leading provider of human hematological products and services, is pleased to announce the opening of a new, 3600 sq ft LeukoLab cell collection facility […]
A Donor-Centric Approach to Cell and Gene Therapy
February 3, 2022In the past decade, emerging therapeutic modalities like cell and gene therapies have opened up new treatment options for previously intractable diseases, changing the industry needs for primary tissues. While […]
AllCells Announces First to Market Launch of In Stock GMP-Compliant Cryopreserved Leukopaks
January 28, 2022Collected from qualified healthy donors that meet baseline FDA 21 CFR 1271 requirements, industry’s first In Stock GMP-compliant Cryopreserved Leukopaks significantly decrease lead time AllCells, the industry leader in the […]
FAQ Series: The Science Behind Cryopreservation
January 11, 2022Primary cells, such as those isolated from the bone marrow or peripheral blood, are important for a wide scope of research and clinical applications – from studying molecular mechanisms driving disease progression, to […]
GMP-Compliant Leukopaks for Allogeneic Cell Therapies
December 13, 2021Adoptive cell therapies (ACTs), which is a treatment based on transferring cells (most often immune cells) into a patient, have revolutionized the standard of care to treat a broad range […]
GMP-Compliant Leukopaks Mitigate Risk in Cell and Gene Therapy Workflows
December 13, 2021Isolated human primary cells are able to retain the morphological and functional characteristics of their tissue of origin, which makes them invaluable tools in life sciences to advance our understanding […]
AllCells Announces New GMP Cleanroom
December 13, 2021Expansion of GMP capabilities to support the rapidly growing cell and gene therapy industry AllCells Alameda, CA Expands GMP Processing Capabilities AllCells, the industry leader in the procurement and customization […]
